Search

Author/Creator Mayer, Petra

1. Activity of the CD40 antagonistic antibody lucatumumab – insights from CLL-niche mimicking xenografts and fludarabine combinations. Issue 9 (1st September 2016)

Authors:
Stiefelhagen, Marius; Gigel, Carola; Vasyutina, Elena; Möllmann, Michael; Breuer, Alexandra; Mayer, Petra; Dürig, Jan; Herling, Marco
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 9(2016:Sep.)
Page Start:
2235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance. Issue 3 (23rd February 2019)

Authors:
Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Dürig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco; Hop...
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 3(2019)
Page Start:
649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Next‐generation amplicon TRB locus sequencing can overcome limitations of flow‐cytometric Vβ expression analysis and confirms clonality in all T‐cell prolymphocytic leukemia cases. Issue 11 (10th November 2018)

Authors:
Kotrova, Michaela; Novakova, Michaela; Oberbeck, Sebastian; Mayer, Petra; Schrader, Alexandra; Knecht, Henrik; Hrusak, Ondrej; Herling, Marco; Brüggemann, Monika
Journal:
Cytometry
Issue:
Volume 93:Issue 11(2018)
Page Start:
1118
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search